首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Syndecan‐1 limits the progression of liver injury and promotes liver repair in acetaminophen‐induced liver injury in mice
【24h】

Syndecan‐1 limits the progression of liver injury and promotes liver repair in acetaminophen‐induced liver injury in mice

机译:Syndecan-1限制了肝损伤的进展,并促进了乙酰氨基酚诱导的小鼠肝损伤的肝脏修复

获取原文
获取原文并翻译 | 示例
       

摘要

Accidental or intentional misuse of acetaminophen (APAP) is the leading cause of acute liver failure in the Western world. Although mechanisms that trigger APAPinduced liver injury (AILI) are well known, those that halt the progression of APAP liver disease and facilitate liver recovery are less understood. Heparan sulfate proteoglycans (HSPGs) bind to and regulate various tissue injury factors through their heparan sulfate (HS) chains, but the importance of HSPGs in liver injuryin vivo remains unknown. Here, we examined the role of syndecan1, the major cellsurface HSPG of hepatocytes, in AILI. Ablation of syndecan1 in mice led to unopposed progression of liver injury upon APAP overdose. However, direct APAP hepatoxicity and liver injury at early times postAPAP overdose were unaffected by syndecan1, suggesting that syndecan1 influences later mechanisms that lead to liver repair. The exuberant liver injury phenotypes in syndecan1 null (Sdc1/ ) mice were traced to a deficiency in protein kinase B (Akt) activation in hepatocytes, which led to a delayed increase in glycogen synthase kinase3?(GSK3?mediated hepatocyte apoptosis. Inhibition of Akt worsened, whereas inhibition of GSK3?and caspases protected mice from AILI. Moreover, administration of purified syndecan1, HS, or engineered heparan compounds containing 2O sulfate groups rescuedSdc1/ mice from AILI by potentiating Akt signaling and inhibiting GSK3?mediated apoptosis in hepatocytes. In addition, HS showed a significantly prolonged therapeutic efficacy as compared toN acetylcysteine.Conclusion : These results demonstrate that 2O sulfated domains in syndecan1 HS halt disease progression and promote liver repair by enhancing hepatocyte survival in AILI. We propose that syndecan1 is a critical endogenous factor that controls the balance between prosurvival signaling and apoptosis in hepatocytes in APAP liver disease. (Hepatology 2017;66:16011615).
机译:意外或故意滥用乙酰氨基酚(APAP)是西方世界急性肝衰竭的主要原因。虽然触发致使肝损伤(AILI)的机制是众所周知的,但那些停止APAP肝病的进展并促进肝脏恢复的肝脏损伤的机制较少理解。硫酸普乙肝素蛋白多糖(Hspgs)通过普通硫酸乙酰氨酸(HS)链结合并调节各种组织损伤因子,但Hspgs在肝脏损伤体内的重要性仍然未知。在这里,我们研究了肝细胞的主要细胞表面Hspg的Syndecan1的作用。在小鼠中的Syndecan1的消融导致APAP过量时未随肝损伤进展。然而,早期肝毒性和肝脏损伤在早期服用过量服用的肝毒性和肝损伤不受Syndecan1的影响,表明Syndecan1影响后期导致肝脏修复的机制。将Syndecan1 Null(SDC1 /)小鼠中常肝损伤表型进行追溯到肝细胞中蛋白激酶B(AKT)活化的缺乏,这导致糖原合酶Kinase3的延迟增加?(GSK3?介导的肝细胞凋亡。抑制AKT恶化,而GSK3的抑制作用?和胱天蛋白酶受到艾利的保护小鼠。此外,通过增强AKT信号传导和抑制GSK3介导的肝细胞介导的细胞凋亡,含有2O硫酸盐基团的纯化的Syndecan1,HS或工程化普对普林化合物。此外,Hs显示出吨乙酰琥珀酰琥珀酰琥珀酰琥珀酸酯的治疗效果显着延长了治疗效果。结论:这些结果表明,通过增强AILI中的肝细胞存活,Syndecan1 HS HALT疾病进展中的2O硫酸化结构域。我们提出了Syndecan1是一种关键的内源因子控制APAP肝脏肝细胞中瘙痒信号传导和细胞凋亡的平衡是的。 (2017年肝脏; 66:16011615)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号